Abstract

Background:Identification of a normal range for biomarkers, based on pregnancy outcomes (caused by their high or low values) is of special importance in clinical studies. As some pregnancy outcomes can happen in both high and low levels of biomarkers, the receiver-operating characteristic (ROC) curve is unsuitable for identifying these levels separately; rather, a statistical method is preferable which identifies both levels simultaneously.Objectives:To this effect, our research introduces a generalization of ROC curve (by using a number of related consequences) to identify a normal range for the biomarker. Practically, the study intends to identify a normal range of hemoglobin in the first trimester of pregnancy to prevent adverse outcomes that can be caused by high and low levels of hemoglobin.Patients and Methods:The current article introduces an ROC generalization curve to determine a normal range for biomarkers based on a number of pregnancy outcomes, which may occur in high and low levels of biomarkers. Simulated data were also used to compare the current method with the ROC curve method. Our data collected from a cohort study carried out on 600 pregnant women referring to Milad Hospital in Tehran, Iran in 2010. The data comprised hemoglobin level in the first trimester of pregnancy as well as pregnancy outcomes such as preterm delivery, low birth weight, preeclampsia, and gestational diabetes. We calculated an estimation of the normal range of hemoglobin for the study population. Statistical analysis was carried out by R software, version 3.0.2.Results:Results from the simulation study indicated that, the new method was better than the methods which used two ROC curves separately with regard to sensitivity and specificity. In this method, the level of normal hemoglobin in the first trimester ranged from 10 to 12.4 with sensitivity and specificity levels of 76.2% and 48% respectively, which is higher than previous studies.Conclusions:With regard to the normal range of biomarkers, our method yielded greater sensitivity and specificity levels than methods using the ROC curve, which separately analyzes the data, particularly in occasions with common consequences in high and low levels of the biomarker.

Highlights

  • Identification of a normal range for biomarkers, based on pregnancy outcomes is of special importance in clinical studies

  • Other types of questions arise in clinical issues, as they mostly deal with identification of a normal range for biomarkers, and certain pregnancy outcomes can happen at both the high and low levels of biomarkers

  • The statistical method used in most clinical researches consists of two separate receiveroperating characteristic (ROC) curves to detect cutoff points for the normal range; in other words, one ROC curve to detect a cutoff point for the high level of the normal range and another one for the lower level

Read more

Summary

Introduction

Identification of a normal range for biomarkers, based on pregnancy outcomes (caused by their high or low values) is of special importance in clinical studies. Patients and Methods: The current article introduces an ROC generalization curve to determine a normal range for biomarkers based on a number of pregnancy outcomes, which may occur in high and low levels of biomarkers. Results: Results from the simulation study indicated that, the new method was better than the methods which used two ROC curves separately with regard to sensitivity and specificity. Conclusions: With regard to the normal range of biomarkers, our method yielded greater sensitivity and specificity levels than methods using the ROC curve, which separately analyzes the data, in occasions with common consequences in high and low levels of the biomarker. The application of such methods, along with common unpleasant results, will cause some problems that are discussed below

Objectives
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.